Early discharge. Risks, benefits, and who decides.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 9779333)

Published in Clin Perinatol on September 01, 1998

Authors

M Kiely1, M A Drum, W Kessel

Author Affiliations

1: Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services, Rockville, Maryland, USA.

Articles by these authors

Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell (1992) 2.15

Early discharge and evidence-based practice. Good science and good judgment. JAMA (1997) 1.70

Pediatric research in office settings (PROS): a national practice-based research network to improve children's health care. Pediatrics (1998) 1.59

Factors associated with use of preventive dental and health services among U.S. adolescents. J Adolesc Health (2001) 1.39

Ethnicity, location, age, and fluoridation factors in baby bottle tooth decay and caries prevalence of Head Start children. Public Health Rep (1992) 1.03

Preconceptional and prenatal multivitamin-mineral supplement use in the 1988 National Maternal and Infant Health Survey. Am J Public Health (1996) 1.02

Collaborative office rounds: continuing education in the psychosocial/developmental aspects of child health. Pediatrics (1997) 0.93

Familial Sotos syndrome (cerebral gigantism): craniofacial and psychological characteristics. Am J Med Genet (1985) 0.89

Osteonectin, bone proteoglycan, and phosphophoryn defects in a form of bovine osteogenesis imperfecta. Proc Natl Acad Sci U S A (1984) 0.86

Osteonectin content in human osteogenesis imperfecta bone shows a range similar to that of two bovine models of OI. Calcif Tissue Int (1987) 0.83

Oral manifestations of the Rieger syndrome: report of case. J Am Dent Assoc (1985) 0.80

Elimination of radioactivity following administration of [15,16-3H]naltrexone to rats and guinea pigs. Drug Metab Dispos (1978) 0.78

Federal programs affecting rural perinatal health care. J Rural Health (1989) 0.75

Naltrexone metabolism and sustained release following administration of an insoluble complex to rhesus monkeys and guinea-pigs. J Pharm Pharmacol (1983) 0.75